<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03119168</url>
  </required_header>
  <id_info>
    <org_study_id>E17034</org_study_id>
    <nct_id>NCT03119168</nct_id>
  </id_info>
  <brief_title>Effect of Simethicone on Screening Colonoscopy</brief_title>
  <official_title>The Effect Of Adding High Dose Simethicone To A Standard Polyethylene Glycol Preparation On Adenoma Detection Rate During Screening Colonoscopy: A Randomized Controlled Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University Health Sciences Center, El Paso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Tech University Health Sciences Center, El Paso</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is evaluating the effect of adding a high dose of simethicone to the standard
      polyethylene glycol preparation for screening colonoscopy in the quality of the preparation ,
      adenoma detection rate and withdrawal times.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A proper bowel preparation is key to a thorough and safe colonoscopy. Several factors affect
      the mucosal visualization during colonoscopy, and consequently the quality of such
      evaluation. Undoubtedly, this can have unfavorable implications like missed lesions. One of
      the most commonly encountered scenarios is the presence of multiple bubbles that interfere
      with mucosal visualization. When this occurs, simethicone (an antifoam agent used to reduce
      bloating when ingested orally) is injected through the colonoscope to eliminate the bubbles
      and get a clear view of the mucosa. A few studies have used oral simethicone in conjunction
      with oral preparation agents (PEG, magnesium citrate, sodium phosphate) in an attempt to
      improve the quality of the preparation. Unfortunately these studies have not used the exact
      same preparation agent with and without simethicone, making it difficult to draw conclusions
      on its efficacy. However, it is important to understand that simethicone is not intended to
      decrease the amount of stool in the colon, and it's purpose is to decrease the amount of
      bubbles interfering with the visualization of the mucosa provided that there is no stool
      present . Furthermore, it is unclear if adding simethicone to a standard bowel preparation
      makes a significant difference in key aspects of screening colonoscopy such as adenoma
      detection rate or withdrawal times. This prospective randomized controlled, observer blinded
      study at Texas Tech University Health Sciences Center in El Paso, aims at studying the effect
      of simethicone on the overall colon preparation as well as on adenoma detection rate and
      withdrawal times.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 15, 2017</start_date>
  <completion_date type="Actual">April 10, 2019</completion_date>
  <primary_completion_date type="Actual">April 10, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adenoma Detection Rate</measure>
    <time_frame>25 minutes</time_frame>
    <description>The number of adenomatous polyps removed at colonoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Withdrawal Times</measure>
    <time_frame>6-10 minutes</time_frame>
    <description>Amount spent withdrawing the scope during the colonoscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colon Preparation</measure>
    <time_frame>25 minutes</time_frame>
    <description>Boston Bowel Preparation Scale (BBPS): scale that rates the quality of the colon preparation based on the amount of stool present. 0:solid stool that cannot be cleared; 1:areas not well seen due to residual stool and/or opaque liquid; 2:small fragments of stool and/or opaque liquid, but mucosa seen well; 3:no residual stool or opaque liquid seen. Score determined by adding the score of each individual segment of the colon (right side, transverse and left side). Scores range from 0 to 3 in each segment, therefore, a total composite score ranges from 0 (poor) to 9 (excellent).
Bubble Score (BS): scale that rates the amount of bubbles present in the colon. 0:no or minimal bubbles; 1:bubbles covering up to half the luminal diameter; 2:bubbles covering the circumference of the lumen; 3:bubbles filling the entire lumen. Score determined the same way as BBPS score but in this case a total score of 0 is excellent and 9 is poor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraprocedural Use of Simethicone</measure>
    <time_frame>6-10 minutes</time_frame>
    <description>The number of colonoscopies during which the endoscopist requested simethicone to be flushed through the endoscope.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">268</enrollment>
  <condition>Adenoma Colon</condition>
  <arm_group>
    <arm_group_label>Simethicone solution + Polyethylenglycol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm of the study will include the patients assigned to take simethicone solution with their colon preparations ( 4L Polyethyleneglycol)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Polyethylenglycol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm of the study will include the patients assigned to take a regular bowel preparation (4L Polyethylenglycol)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simethicone Solution</intervention_name>
    <description>Patients will be assigned randomly to take Simethicone Solution plus polyethylenglycol</description>
    <arm_group_label>Simethicone solution + Polyethylenglycol</arm_group_label>
    <other_name>mylicon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Polyethylenglycol</intervention_name>
    <description>Patients in this arm will be randomly assigned to take polyethylenglycol as their regular bowel preparation</description>
    <arm_group_label>Polyethylenglycol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients between the ages of 30-80 scheduled for screening colonoscopy.

          2. Male and female patients

          3. Ambulatory patients

          4. Signed informed consent form

        Exclusion Criteria:

          1. Previous colonic surgery

          2. Patient with mental/physical condition that impairs oral ingestion of preparation

          3. Allergy or hypersensitivity to simethicone

          4. Patients with limited mobility (bedridden patients)

          5. Patients with gastrointestinal obstruction

          6. Patients with gastroparesis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio H Mendoza-Ladd, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech University Health Sciences Center, El Paso</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Texas Tech university Health Sciences Center El Paso</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Park JJ, Lee SK, Jang JY, Kim HJ, Kim NH. The effectiveness of simethicone in improving visibility during colonoscopy. Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1321-5.</citation>
    <PMID>19950784</PMID>
  </reference>
  <reference>
    <citation>Yoo IK, Jeen YT, Kang SH, Lee JH, Kim SH, Lee JM, Choi HS, Kim ES, Keum B, Chun HJ, Lee HS, Kim CD. Improving of bowel cleansing effect for polyethylene glycol with ascorbic acid using simethicone: A randomized controlled trial. Medicine (Baltimore). 2016 Jul;95(28):e4163. doi: 10.1097/MD.0000000000004163.</citation>
    <PMID>27428209</PMID>
  </reference>
  <results_reference>
    <citation>Rex DK, Petrini JL, Baron TH, Chak A, Cohen J, Deal SE, Hoffman B, Jacobson BC, Mergener K, Petersen BT, Safdi MA, Faigel DO, Pike IM. Quality indicators for colonoscopy. Gastrointest Endosc. 2006 Apr;63(4 Suppl):S16-28. Review.</citation>
    <PMID>16564908</PMID>
  </results_reference>
  <results_reference>
    <citation>Hassan C, Fuccio L, Bruno M, Pagano N, Spada C, Carrara S, Giordanino C, Rondonotti E, Curcio G, Dulbecco P, Fabbri C, Della Casa D, Maiero S, Simone A, Iacopini F, Feliciangeli G, Manes G, Rinaldi A, Zullo A, Rogai F, Repici A. A predictive model identifies patients most likely to have inadequate bowel preparation for colonoscopy. Clin Gastroenterol Hepatol. 2012 May;10(5):501-6. doi: 10.1016/j.cgh.2011.12.037. Epub 2012 Jan 10.</citation>
    <PMID>22239959</PMID>
  </results_reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>April 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2017</study_first_posted>
  <results_first_submitted>April 18, 2019</results_first_submitted>
  <results_first_submitted_qc>June 3, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 5, 2019</results_first_posted>
  <last_update_submitted>June 3, 2019</last_update_submitted>
  <last_update_submitted_qc>June 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Tech University Health Sciences Center, El Paso</investigator_affiliation>
    <investigator_full_name>Antonio Mendoza-Ladd</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>screening</keyword>
  <keyword>adenoma detection rate</keyword>
  <keyword>simethicone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simethicone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 10, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/68/NCT03119168/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 2, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/68/NCT03119168/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Simethicone Solution + Polyethylenglycol</title>
          <description>This arm of the study will include the patients assigned to take simethicone solution with their colon preparation (4L Polyethylenglycol)
Simethicone Solution: Patients will be assigned randomly to take Simethicone Solution plus 4 L of polyethylenglycol</description>
        </group>
        <group group_id="P2">
          <title>Polyethylenglycol</title>
          <description>This arm of the study will include the patients assigned to take a regular bowel preparation with 4L Polyethylenglycol
Polyethylenglycol: All patients were assigned to take 4L polyethylenglycol as their regular bowel preparation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="129"/>
                <participants group_id="P2" count="139"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="129"/>
                <participants group_id="P2" count="139"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Simethicone Solution + Polyethylenglycol</title>
          <description>This arm of the study will include the patients assigned to take simethicone solution with their colon preparations
Simethicone Solution: Patients will be assigned randomly to take Simethicone Solution plus polyethylenglycol</description>
        </group>
        <group group_id="B2">
          <title>Polyethylenglycol</title>
          <description>This arm of the study will include the patients assigned to take a regular bowel preparation with Polyethylenglycol
Polyethylenglycol: Patients in this arm will be randomly assigned to take polyethylenglycol as their regular bowel preparation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="129"/>
            <count group_id="B2" value="139"/>
            <count group_id="B3" value="268"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.3" spread="7.55"/>
                    <measurement group_id="B2" value="57" spread="6.02"/>
                    <measurement group_id="B3" value="57" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="92"/>
                    <measurement group_id="B3" value="173"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="111"/>
                    <measurement group_id="B2" value="124"/>
                    <measurement group_id="B3" value="235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="129"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="268"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Count of participants</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="129"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="268"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Adenoma Detection Rate</title>
        <description>The number of adenomatous polyps removed at colonoscopy</description>
        <time_frame>25 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Simethicone Solution + Polyethylenglycol</title>
            <description>This arm of the study will include the patients assigned to take simethicone solution with their colon preparations
Simethicone Solution: Patients will be assigned randomly to take Simethicone Solution plus polyethylenglycol</description>
          </group>
          <group group_id="O2">
            <title>Polyethylenglycol</title>
            <description>This arm of the study will include the patients assigned to take a regular bowel preparation with Polyethylenglycol
Polyethylenglycol: Patients in this arm will be randomly assigned to take polyethylenglycol as their regular bowel preparation</description>
          </group>
        </group_list>
        <measure>
          <title>Adenoma Detection Rate</title>
          <description>The number of adenomatous polyps removed at colonoscopy</description>
          <units>adenomas</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="129"/>
                <count group_id="O2" value="139"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Withdrawal Times</title>
        <description>Amount spent withdrawing the scope during the colonoscopy</description>
        <time_frame>6-10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Simethicone Solution + Polyethylenglycol</title>
            <description>This arm of the study will include the patients assigned to take simethicone solution with their colon preparations
Simethicone Solution: Patients will be assigned randomly to take Simethicone Solution plus polyethylenglycol</description>
          </group>
          <group group_id="O2">
            <title>Polyethylenglycol</title>
            <description>This arm of the study will include the patients assigned to take a regular bowel preparation with Polyethylenglycol
Polyethylenglycol: Patients in this arm will be randomly assigned to take polyethylenglycol as their regular bowel preparation</description>
          </group>
        </group_list>
        <measure>
          <title>Withdrawal Times</title>
          <description>Amount spent withdrawing the scope during the colonoscopy</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="129"/>
                <count group_id="O2" value="139"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="395.7" spread="69.2"/>
                    <measurement group_id="O2" value="399" spread="76.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Colon Preparation</title>
        <description>Boston Bowel Preparation Scale (BBPS): scale that rates the quality of the colon preparation based on the amount of stool present. 0:solid stool that cannot be cleared; 1:areas not well seen due to residual stool and/or opaque liquid; 2:small fragments of stool and/or opaque liquid, but mucosa seen well; 3:no residual stool or opaque liquid seen. Score determined by adding the score of each individual segment of the colon (right side, transverse and left side). Scores range from 0 to 3 in each segment, therefore, a total composite score ranges from 0 (poor) to 9 (excellent).
Bubble Score (BS): scale that rates the amount of bubbles present in the colon. 0:no or minimal bubbles; 1:bubbles covering up to half the luminal diameter; 2:bubbles covering the circumference of the lumen; 3:bubbles filling the entire lumen. Score determined the same way as BBPS score but in this case a total score of 0 is excellent and 9 is poor.</description>
        <time_frame>25 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Simethicone Solution + Polyethylenglycol</title>
            <description>This arm of the study will include the patients assigned to take simethicone solution with their colon preparations
Simethicone Solution: Patients will be assigned randomly to take Simethicone Solution plus polyethylenglycol</description>
          </group>
          <group group_id="O2">
            <title>Polyethylenglycol</title>
            <description>This arm of the study will include the patients assigned to take a regular bowel preparation with Polyethylenglycol
Polyethylenglycol: Patients in this arm will be randomly assigned to take polyethylenglycol as their regular bowel preparation</description>
          </group>
        </group_list>
        <measure>
          <title>Colon Preparation</title>
          <description>Boston Bowel Preparation Scale (BBPS): scale that rates the quality of the colon preparation based on the amount of stool present. 0:solid stool that cannot be cleared; 1:areas not well seen due to residual stool and/or opaque liquid; 2:small fragments of stool and/or opaque liquid, but mucosa seen well; 3:no residual stool or opaque liquid seen. Score determined by adding the score of each individual segment of the colon (right side, transverse and left side). Scores range from 0 to 3 in each segment, therefore, a total composite score ranges from 0 (poor) to 9 (excellent).
Bubble Score (BS): scale that rates the amount of bubbles present in the colon. 0:no or minimal bubbles; 1:bubbles covering up to half the luminal diameter; 2:bubbles covering the circumference of the lumen; 3:bubbles filling the entire lumen. Score determined the same way as BBPS score but in this case a total score of 0 is excellent and 9 is poor.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="129"/>
                <count group_id="O2" value="139"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Boston Bowel Preparation Scale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.9" spread="0.4"/>
                    <measurement group_id="O2" value="8.9" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bubble Scale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.2"/>
                    <measurement group_id="O2" value="2.1" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraprocedural Use of Simethicone</title>
        <description>The number of colonoscopies during which the endoscopist requested simethicone to be flushed through the endoscope.</description>
        <time_frame>6-10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Simethicone Solution + Polyethylenglycol</title>
            <description>The number of colonoscopies during which the endoscopist requested simethicone to be flushed through the endoscope</description>
          </group>
          <group group_id="O2">
            <title>Polyethylenglycol</title>
            <description>The number of colonoscopies during which the endoscopist requested simethicone to be flushed through the endoscope</description>
          </group>
        </group_list>
        <measure>
          <title>Intraprocedural Use of Simethicone</title>
          <description>The number of colonoscopies during which the endoscopist requested simethicone to be flushed through the endoscope.</description>
          <units>colonoscopies</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="129"/>
                <count group_id="O2" value="139"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>60 minutes</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Simethicone Solution + Polyethylenglycol</title>
          <description>Simethicone solution + Polyethylenglycol were received as a bowel prep regimen</description>
        </group>
        <group group_id="E2">
          <title>Polyethylenglycol</title>
          <description>Polyethylenglycol was received as a bowel prep regimen</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="129"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="139"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="129"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="139"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="129"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="139"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study was done at our hospital setting, generalizability can be examined in larger studies</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>The Effect Of Adding High Dose Simethicone To A Standard Polyethylene Glycol Preparation On Adenoma</name_or_title>
      <organization>Texas Tech University Health Sciences Center at El Paso</organization>
      <phone>915-215-4678</phone>
      <email>antonio.mendoza-ladd@ttuhsc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

